Sepsis-induced acute kidney injury revisited: Pathophysiology, prevention and future therapies

Current Opinion in Critical Care

Volumn 20, Issue 6, 2014, Pages 588-595

  Zarbock, Alexander ^a   Gomez, Hernando ^b,c   Kellum, John A ^b,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Inflammation; Microvascular dysfunction; Sepsis; Tubular epithelial cells

Indexed keywords

ACUTE KIDNEY FAILURE; HUMAN; INFLAMMATION; INTERVENTION STUDY; KIDNEY INJURY; KIDNEY TUBULE CELL; MICROCIRCULATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SEPSIS; ACUTE KIDNEY INJURY; COMPLICATION; KIDNEY; VASCULARIZATION;

ACUTE KIDNEY INJURY; HUMANS; KIDNEY; MICROCIRCULATION; SEPSIS;

EID: 84927799518     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000153     Document Type: Review

References (69)

1. Bellomo R, Ronco C, Kellum J.A., et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit care 2004; 8:R204-R212.
2. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35:1837-1843.
3. Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81:819-825.
4. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008; 36:S146-S151.
5. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351:159-169.
6. Gomez H, Ince C, De Backer D, et al. A unified theory ofsepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41:3-11.
7. Le Dorze M, Legrand M, Payen D., Ince C. The role of the microcirculation in acute kidney injury. Curr Opin Crit Care 2009; 15:503-508.
8. Prowle JR, Ishikawa K, May C.N., Bellomo R. Renal blood flow during acute renal failure in man. Blood Purif 2009; 28:216-225.
9. Murugan R, Karajala-Subramanyam V, Lee M., et al. Acute kidney injury in nonsevere pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010; 77:527-535.
10. Takasu O, Gaut JP, Watanabe E, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 2013; 187:509-517.
11. Lerolle N, Nochy D, Guerot E., et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocyte infiltration. Intensive Care Med 2010; 36:471-478.
12. Redfors B, Bragadottir G, Sellgren J., et al. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011; 37:60-67.
13. Asfar P, Meziani F, Hamel J.F., et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370:1583-1593.
14. Spronk PE, Ince C, Gardien M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396.
15. Donati A, Damiani E, Botticelli L., et al. The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome. BMC Anesthesiol 2013; 13:25.
16. De Backer D, Creteur J, Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104.
17. Di Giantomasso D, May CN, Bellomo R. Vital organ blood flow during hyperdynamic sepsis. Chest 2003; 124:1053-1059.
18. Chvojka J, Sykora R, Krouzecky A., et al. Renal haemodynamic, microcircu-latory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care 2008; 12:R164.
19. Bezemer R, Legrand M, Klijn E., et al. Real-time assessment of renal cortical microvascular perfusion heterogeneities using near-infrared laser speckle imaging. Opt Express 2010; 18:15054-15061.
20. Deruddre S, Cheisson G, Mazoit J.X., et al. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med 2007; 33:1557-1562.
21. De Backer D, Donadello K, Taccone F.S., et al. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 2011; 1:27.
22. Prowle JR, Echeverri JE, Ligabo E.V., et al. Fluid balance and acute kidney injury. Nat Rev Nephrol 2010; 6:107-115.
23. Bagshaw SM, Brophy PD, Cruz D, Ronco C. Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care 2008; 12:169.
24. Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemo-dynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-1948.
25. Holthoff JH, Wang Z, Seely K.A., et al. Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 2012; 81:370-378.
26. Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014; 10:37-47
27. Rajendram R, Prowle JR. Venous congestion: are we adding insult to kidney injury in sepsis? Crit Care 2014; 18:104.
28. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78:539-552.
29. Seely KA, Holthoff JH, Burns S.T., et al. Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2011; 301:F209-F217.
30. Trzeciak S, Cinel I, Phillip Dellinger R, et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15:399-413.
31. Aksu U, Demirci C, Ince C. The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitric oxide. Contrib Nephrol 2011; 174:119-128.
32. Heemskerk S, Masereeuw R, Russel F.G., Pickkers P. Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol 2009; 5:629-640.
33. Tiwari MM, Brock RW, Megyesi J.K., et al. Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol Renal Physiol 2005; 289:F1324-F1332.
34. Payen D, Lukaszewicz AC, Legrand M, et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One 2012; 7:e35838.
35. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851.
36. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-820.
37. Chan JK, Roth J, Oppenheim J.J., et al. Alarmins: awaiting a clinical response. J Clin Invest 2012; 122:2711-2719.
38. Herter JM, Rossaint J, Spieker T., Zarbock A. Adhesion molecules involved in neutrophil recruitment during sepsis-induced acute kidney injury. J Innate Immun 2014; 6:597-606
39. Singbartl K, Bishop JV, Wen X, et al. Differential effects of kidney-lung crosstalk during acute kidney injury and bacterial pneumonia. Kidney Int 2011; 80:633-644.
40. Brown KA, Brain SD, Pearson J.D., et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368:157-169.
41. Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol 2008; 172:1-7.
42. El-Achkar TM, Hosein M, Dagher PC. Pathways of renal injury in systemic gram-negative sepsis. Eur J Clin Invest 2008; 38:39-44.
43. Kruger B, Krick S, Dhillon N., et al. Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 2009; 106:3390-3395.
44. Kalakeche R, Hato T, Rhodes G., et al. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress inthe downstream S2 segment. J Am Soc Nephrol 2011; 22:1505-1516.
45. Mudaliar H, Pollock C, Komala M.G., et al. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013; 305:F143-F154
46. Lin M, Yiu WH, Wu HJ, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012; 23:86-102.
47. Wu L, Gokden N, Mayeux PR. Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 2007; 18:1807-1815.
48. Biancone L, Conaldi PG, Toniolo A, Camussi G. Escherichia coli porin induces proinflammatory alterations in renal tubular cells. Exp Nephrol 1997; 5:330-336.
49. Mariano F, Cantaluppi V, Stella M., et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008; 12:R42.
50. Morrell ED, Kellum JA, Hallows K.R., Pastor-Soler NM. Epithelial transport during septic acute kidney injury. Nephrol Dial Transplant 2013; 29:1312-1319.
51. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548.
52. Brealey D, Brand M, Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223.
53. Brealey D, Karyampudi S, Jacques T.S., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497.
54. Zhan M, Brooks C, Liu F., et al. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 2013; 83:568-581.
55. Sansanwal P, Yen B, Gahl W.A., et al. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 2010; 21:272-283.
56. Meersch M, Schmidt C, Van Aken H, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One 2014; 9:e93460
57. Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014; 189:932-939.
58. Kashani K, Al-Khafaji A, Ardiles T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25
59. Mandal S, Guptan P, Owusu-Ansah E, Banerjee U. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev Cell 2005; 9:843-854.
60. Aregger F, Uehlinger DE, Witowski J, et al. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury. Kidney Int 2013; 85:909-919.
61. Kellum JA, Venkataraman R, Powner D., et al. Feasibility study of cytokine removal by hemoadsorption in brain-dead humans. Crit Care Med 2008; 36:268-272.
62. Cantaluppi V, Assenzio B, Pasero D., et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Medicine 2008; 34:1638-1645.
63. Peng ZY, Wang HZ, Carter M.J., et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int 2012; 81:363-369.
64. Heemskerk S, Masereeuw R, Moesker O., et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 2009; 37:417-423.
65. Pickkers P, Heemskerk S, Schouten J., et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized doubleblind placebo-controlled trial. Crit Care 2012; 16:R14.
66. Susantitaphong P, Perianayagam MC, Tighiouart H, et al. Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract 2013; 123:67-73.
67. Boerma EC, Koopmans M, Konijn A., et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med 2010; 38:93-100.
68. Liakopoulos OJ, Choi YH, Haldenwang P.L., et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30, 000 patients. Eur Heart J 2008; 29:1548-1559.
69. Song YR, Lee T, You S.J., et al. Prevention of acute kidney injury by erythro-poietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30:253-260.